In vivo antitumor effects of bitter principles from the antlered form of fruiting bodies of Ganoderma lucidum

Journal of Natural Medicines

Volumn 60, Issue 1, 2006, Pages 42-48

  Gao, Jiang Jing ^a   Hirakawa, Akiko ^a   Min, Byung Sun ^a,b   Nakamura, Norio ^a   Hattori, Masao ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Antitumor effect; Bitter principle; Cytotoxicity; Ganoderiol F; Ganoderma lucidum; Lewis lung carcinoma; Triterpene

Indexed keywords

DOXORUBICIN; GANODERIOL F; GANODERMA LUCIDUM EXTRACT; GANODERMADIOL; GANODERMANONTRIOL; GANODERMATRIOL; LUCIDUMOL B; PLANT MEDICINAL PRODUCT; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ISOLATION; FEMALE; GANODERMA LUCIDUM; HUMAN; IN VIVO STUDY; INOCULATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; TUMOR GROWTH;

EID: 42249094011     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-005-0003-5     Document Type: Article

References (30)

1. SP Wasser AL Weis 1999 Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspective Int J Med Mushrooms 1 31 62
2. WMW Cheung WS Hui PWK Chu NY Chiu 2000 Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells FEBS Lett 486 291 296
3. FC Yang SS Ke SS Kuo 2000 Effect of fatty acids on the mycelial growth polysaccharide formation by Ganoderma lucidum in shake flask cultures Enzyme Microb Technol 27 295 301
4. Lin ZB (2001) Pharmacological effects and clinical applications of Ganoderma lucidum. Modern research of Ganoderma lucidum, 2nd edn. Beijing Medical University Press, pp 284-309
5. T Mizuno H Kawagishi H Ito K Shimura 1988 Immunostimulative antitumor effects of β-d-glucans and chitin substances isolated from some medicinal mushrooms Bull Fac Agr Shizuoka Univ 38 29 35
6. E Furusawa SC Chou S Furusawa A Hirazami Y Dang 1992 Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergetic mice Phytother Res 6 300 304
7. L Zhang M Zhang Q Zhou J Chen F Zeng 2000 Solution properties of antitumor sulfated derivatives of α-(1→3)-d-glucan from Ganoderma lucidum Biosci Biotechnol Biochem 64 1026 1033
8. XF Bao Y Zhen L Ruan JN Fang 2002 Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum Chem Pharm Bull 50 623 629
9. Y Gao S Zhou W Jiang M Huang X Dai 2003 Effects of ganopoly (a Ganoderma lucidum polysaccharides extract) on the immune functions in advanced-stage cancer patients Immunol Invest 32 201 215
10. Min BS, Gao JJ, Hattori M (2005) Bitter principles from the fruiting bodies and spores of Ganoderma lucidum. Curr Top Phytochem (in press)
11. SB Lin CH Li SS Lee LS Kan 2003 Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest Life Sci 72 2381 2390
12. Y Kimura M Taniguchi K Baba 2002 Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance Anticancer Res 22 3309 3318
13. BS Min JJ Gao N Nakamura M Hattori 2000 Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells Chem Pharm Bull 48 1026 1033
14. JJ Gao BS Min EM Ahn N Nakamura HK Lee M Hattori 2002 New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells Chem Pharm Bull 50 837 840
15. JJ Gao N Nakamura BS Min A Hirakawa F Zuo M Hattori 2004 Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high performance liquid chromatography and its application to the evaluation of ganoderma products Chem Pharm Bull 52 688 695
16. M Arisawa A Fujita M Saga H Fukumura T Hayashi M Shimizu N Morita 1986 Three new lanostanoids from Ganoderma lucidum J Nat Prod 49 621 625
17. T Nishitoba K Oda H Sato S Sakamura 1988 Novel triterpenoids from the fungus Ganoderma lucidum Agric Biol Chem 52 367 372
18. A Fujita M Arisawa M Saga T Hayashi N Morita 1986 Two new lanostanoids from Ganoderma lucidum J Nat Prod 49 1122 1125
19. H Sato T Nishitoba S Shirasu K Oda S Sakamura 1986 Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi) Agric Biol Chem 50 2887 2890
20. P Skehan R Storeng D Scudiero A Monks J McMahon D Vistica JT Warren H Bokesch S Kenney MR Boyd 1990 New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 1107 1112
21. L Wu AM Smythe SF Stinson LA Mullendore A Monks DA Scudiero KD Paull AD Koutsoukos LV Rubinstein MR Boyd RH Shoemaker 1992 Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening Cancer Res 52 3029 3034
22. T Kato K Sato H Kakinuma Y Matsuda 1994 Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice Cancer Res 54 5143 5147
23. HS Kim S Kacew BM Lee 1999 In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor) Carcinogenesis 20 1637 1640
24. BS Min JJ Gao YH Lee N Nakamura M Hattori 2004 Chemical and biological evaluation of germinated and mature antler-shaped fruiting bodies of Ganoderma lucidum Nat Med 58 91 97
25. XF Bao CP Liu JN Fang XY Li 2001 Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst Carbohydr Res 332 67 74
26. X Liu JP Yuan CK Chung XJ Chen 2002 Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum Cancer Lett 182 155 161
27. DH Kim SB Shim NJ Kim IS Jang 1999 β-Glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 22 162 164
28. SY Lee HM Rhee 1990 Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action Chem Pharm Bull 38 1359 1364
29. Y Komoda M Shimizu Y Sonoda Y Sato 1989 Ganodermic acid and its derivatives as cholesterol synthesis inhibitors Chem Pharm Bull 37 531 533
30. Shigeno T (2002) Clinical antlered form Ganoderma lucidum. President Inc. Press, pp 18-19